ABBV-8736

N/A

Report date: 2026/02/25 20:02:36

Base Information

Drug NameABBV-8736
Drug Alias NameABBV-8736
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTriggering receptor expressed on myeloid cells 1 inhibitors
TargetsTriggering receptor expressed on myeloid cells 1
Therapy Area/IndicationsCrohn DiseaseInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[32] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbbvie Inc
Inactive CompaniesN/A
Active IndicationsCrohn DiseaseInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A